Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
47 studies found for:    " January 27, 2010":" February 26, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
2 Withdrawn An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons
Conditions: HIV;   HIV Infections
Intervention: Drug: Valacyclovir
3 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
4 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
5 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
6 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
7 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
8 Terminated Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
9 Completed
Has Results
Cryptococcal Optimal ART Timing Trial
Conditions: Cryptococcal Meningitis;   HIV Infections;   AIDS
Interventions: Drug: efavirenz;   Biological: nucleoside backbone
10 Completed Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
Intervention:
11 Completed Adherence Intervention for People With Low-literacy
Condition: HIV Infections
Interventions: Behavioral: Stick To It;   Behavioral: Standard medication adherence counseling;   Behavioral: Health Counseling
12 Completed Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark
Condition: HIV Infections
Intervention:
13 Completed The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya
Conditions: AIDS;   Antiretroviral Therapy;   Medication Adherence;   HIV Infections
Intervention: Behavioral: Short Message Services to Support ARV therapy adherence
14 Completed HIV Prevention Intervention for People Living With HIV/AIDS
Condition: HIV Infections
Interventions: Behavioral: In The Mix;   Behavioral: Information Support Group
15 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
16 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
17 Completed Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
18 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
19 Recruiting Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo
20 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years